Immunogen Inc (DELISTED) (IMGN:DL)
31.23
0.00 (0.00%)
USD |
NASDAQ |
Feb 13, 16:00
Immunogen Free Cash Flow (Quarterly): 1.416M for Sept. 30, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 1.416M |
| June 30, 2023 | -66.82M |
| March 31, 2023 | -73.93M |
| December 31, 2022 | -60.45M |
| September 30, 2022 | -64.81M |
| June 30, 2022 | -64.20M |
| March 31, 2022 | -41.71M |
| December 31, 2021 | -46.24M |
| September 30, 2021 | -35.17M |
| June 30, 2021 | -43.93M |
| March 31, 2021 | -45.51M |
| December 31, 2020 | 8.433M |
| September 30, 2020 | -31.42M |
| June 30, 2020 | -28.22M |
| March 31, 2020 | -28.34M |
| December 31, 2019 | -32.64M |
| September 30, 2019 | -35.41M |
| June 30, 2019 | -31.24M |
| March 31, 2019 | 8.076M |
| December 31, 2018 | -42.31M |
| September 30, 2018 | -41.95M |
| June 30, 2018 | -36.42M |
| March 31, 2018 | -50.98M |
| December 31, 2017 | -29.68M |
| September 30, 2017 | 45.87M |
| Date | Value |
|---|---|
| June 30, 2017 | 23.74M |
| March 31, 2017 | -33.40M |
| September 30, 2016 | -49.03M |
| June 30, 2016 | -34.68M |
| March 31, 2016 | -29.56M |
| December 31, 2015 | -35.89M |
| September 30, 2015 | -34.73M |
| June 30, 2015 | -31.37M |
| March 31, 2015 | 5.629M |
| December 31, 2014 | -16.37M |
| September 30, 2014 | -20.61M |
| June 30, 2014 | -22.39M |
| March 31, 2014 | -15.51M |
| December 31, 2013 | 0.221M |
| September 30, 2013 | -24.15M |
| June 30, 2013 | -12.97M |
| March 31, 2013 | -6.355M |
| December 31, 2012 | -22.78M |
| September 30, 2012 | -21.97M |
| June 30, 2012 | -17.30M |
| March 31, 2012 | 4.971M |
| December 31, 2011 | -12.75M |
| September 30, 2011 | -12.12M |
| June 30, 2011 | -14.43M |
| March 31, 2011 | -13.11M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-73.93M
Minimum
Mar 2023
8.433M
Maximum
Dec 2020
-40.01M
Average
-38.56M
Median
Free Cash Flow (Quarterly) Benchmarks
| AbbVie Inc | 4.548B |
| Pfizer Inc | 4.196B |
| Johnson & Johnson | 2.85B |
| Merck & Co Inc | -743.00M |
| Cerevel Therapeutics Holdings Inc | -98.32M |